BC Week In Review | Feb 10, 2014
Company News

PreCision Dermatology, Valeant Pharmaceuticals deal

Valeant will acquire dermatology company PreCision for $475 million in cash, plus up to an additional $25 million in sales-based milestones. PreCision markets dermatology products, including mid-potency topical steroid Locoid , BenzEFoam Emollient Foam for acne...
BC Week In Review | Dec 6, 2010
Company News

Collegium dermatology news

Collegium spun out its Onset Therapeutics LLC subsidiary into newco Precision Dermatology Inc. (Cumberland, R.I.), which will focus on developing and commercializing dermatology products. The spin off includes a GMP manufacturing facility, the Delevo foam...
BC Week In Review | Jun 14, 2010
Company News

Onset Therapeutics dermatology news

Onset completed its previously announced 50% sales force expansion. Onset said the expansion is a result of the U.S. growth of the company's marketed dermatology foam products, including BenzEFoam Emollient Foam for acne and Hylatopic...
Items per page:
1 - 3 of 3